The journey towards mental well-being is receiving a significant boost as ifeel, a leading digital mental health solution provider, announces the successful closure of a $20 million Series B investment round. The round was jointly led by FinTLV Ventures and Korelya Capital, with participation from existing investors SCOR Ventures, Nauta, and UNIQA Ventures. This infusion of capital underscores ifeel’s commitment to revolutionizing mental health care by leveraging technology, clinical expertise, and a human-centric approach.
Founded in 2017, ifeel has been dedicated to maximizing access to mental health care for individuals, large corporations, and insurers worldwide. By integrating cutting-edge AI models into diagnostic, self-care, and therapeutic processes, ifeel has set a new standard for clinically grounded and financially viable mental health solutions.
Since its inception, ifeel has experienced exponential growth, solidifying its position as a trusted partner for major corporations and insurers across multiple countries. Notable clients include Glovo, Insud Pharma, SCOR SE, Cabify, Travelperk, H&M, Wellhub, and Thoughtworks, among others. Through a combination of prevention and intervention, ifeel’s global mental well-being solution has positively impacted over 1 million employees worldwide, with a remarkable 200% growth in the previous year alone.
Gil Arazi, Founder and Managing Partner of FinTLV Ventures, expressed confidence in ifeel’s ability to address the escalating mental health challenges faced by employees and insured populations, stating,
“This investment is timely and essential as it supports our thesis that the insurance industry should prioritize prevention and preventative solutions.”
Franco Danesi, Partner at Korelya Capital, commended ifeel’s innovative approach, emphasizing the company’s unique product offering and its potential to transform mental health care.
“Amir and the ifeel team are on a mission to tackle one of the biggest societal challenges of our times,”
Danesi remarked.
“We are impressed by ifeel’s product, which we believe is truly unique in the market.”
With a total of $40 million raised since its inception, ifeel is poised for further expansion and innovation. The latest investment round will enable the company to strengthen its commercial presence in existing and new markets while deepening its product and innovation capabilities in the mental health space.
Amir Kaplan, CEO of ifeel, highlighted the urgent need for structural change in the mental health industry, stating,
“In a time when having the right clinical insights on a patient population is critical to preventing, treating, and underwriting mental health disorders appropriately, ifeel emerges as a solution that is capable of driving optimal mental health outcomes at scale.”
As ifeel continues to lead the charge towards a more mentally healthy future, the company remains committed to its mission of providing accessible, effective, and compassionate mental health care to all.